Hapvida Participacoes e Investimentos SA (HAPV3) Price & Analysis

― Followers

HAPV3 Stock Chart & Stats

$6.54

$0.45(7.39%)

Aug 21, 2026

―

Day’s Range― - ―

52-Week Range$6.01 - $42.66

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

R$3.25B

Enterprise Value$12.50K

Total Cash (Recent Filing)R$7.89B

Total Debt (Recent Filing)R$15.54B

Price to Earnings (P/E)―

Beta1.35

Next Earnings

Nov 11, 2026

EPS Estimate

0.13

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.37

Shares Outstanding502,630,900

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio0.67

Price to Book (P/B)0.15

Price to Sales (P/S)0.23

P/FCF Ratio-17.62

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)1

Revenue Forecast (FY)R$32.16B

HAPV3 FAQ

What was Hapvida Participacoes e Investimentos SA’s price range in the past 12 months?

Hapvida Participacoes e Investimentos SA lowest stock price was $6.01 and its highest was $42.66 in the past 12 months.

What is Hapvida Participacoes e Investimentos SA’s market cap?

Hapvida Participacoes e Investimentos SA’s market cap is R$3.25B.

When is Hapvida Participacoes e Investimentos SA’s upcoming earnings report date?

Hapvida Participacoes e Investimentos SA’s upcoming earnings report date is Nov 11, 2026 which is in 79 days.

How were Hapvida Participacoes e Investimentos SA’s earnings last quarter?

Hapvida Participacoes e Investimentos SA released its earnings results on Aug 12, 2026. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.129 by $0.091.

Is Hapvida Participacoes e Investimentos SA overvalued?

According to Wall Street analysts Hapvida Participacoes e Investimentos SA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Hapvida Participacoes e Investimentos SA pay dividends?

Hapvida Participacoes e Investimentos SA pays a N/A dividend of $0.081 which represents an annual dividend yield of N/A. See more information on Hapvida Participacoes e Investimentos SA dividends here

What is Hapvida Participacoes e Investimentos SA’s EPS estimate?

Hapvida Participacoes e Investimentos SA’s EPS estimate is 0.13.

How many shares outstanding does Hapvida Participacoes e Investimentos SA have?

Hapvida Participacoes e Investimentos SA has 502,630,900 shares outstanding.

What happened to Hapvida Participacoes e Investimentos SA’s price movement after its last earnings report?

Hapvida Participacoes e Investimentos SA reported an EPS of $0.22 in its last earnings report, beating expectations of $0.129. Following the earnings report the stock price went down -33.09%.

Which hedge fund is a major shareholder of Hapvida Participacoes e Investimentos SA?

Currently, no hedge funds are holding shares in BR:HAPV3

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Hapvida Participacoes e Investimentos SA

Hapvida Participações e Investimentos S.A., operating alongside its affiliated companies, is a key player in the Brazilian healthcare sector. The organization provides a variety of health and dental insurance plans. Its service offerings extend to direct medical and paramedical care, complemented by a suite of diagnostic services such as laboratory analysis, imaging, and ultrasound. Additionally, Hapvida supports educational initiatives by organizing courses, lectures, seminars, and similar events. The company is also involved in the administration, consultancy, deployment, and sale of individual, family, and collective healthcare systems and plans. It manages the reimbursement of medical, dental, hospital, and general healthcare expenses for its members, while simultaneously offering direct medical and hospital services. Hapvida maintains an extensive operational infrastructure, comprising 85 hospitals, 77 emergency units, 318 clinics, and 269 diagnostic centers. The company was founded in 1979 and is headquartered in Fortaleza, Brazil.